Tags

Type your tag names separated by a space and hit enter

[Rational hypertension treatment].
Schweiz Med Wochenschr. 1996 Aug 17; 126(33):1394-9.SM

Abstract

The primary objective of antihypertensive treatment is to prevent the involvement of target-organs, including hypertensive vascular disease of the kidney or left ventricular hypertrophy. Antihypertensive treatment should not worsen other cardiovascular risk factors (e.g. lipids) or impair quality of life. Contemporary efforts to optimize antihypertensive therapy are focused on single-drug therapy and on individualizing treatment according to patients age, sex, race and the presence of concomitant illnesses and therapies, in order to improve compliance and reduce overall cardiovascular morbidity and mortality. Several antihypertensive drugs such as ACE-inhibitors, beta-adrenergic-receptor antagonists, calcium channel blockers, diuretics, alpha-adrenergic-receptor antagonists, and newer substances such as imidazoline-receptor antagonists and angiotensin-II antagonists are discussed.

Authors+Show Affiliations

Medizinische Klinik, Kantonsspital Chur.

Pub Type(s)

English Abstract
Journal Article

Language

ger

PubMed ID

8830397

Citation

Canova, C R.. "[Rational Hypertension Treatment]." Schweizerische Medizinische Wochenschrift, vol. 126, no. 33, 1996, pp. 1394-9.
Canova CR. [Rational hypertension treatment]. Schweiz Med Wochenschr. 1996;126(33):1394-9.
Canova, C. R. (1996). [Rational hypertension treatment]. Schweizerische Medizinische Wochenschrift, 126(33), 1394-9.
Canova CR. [Rational Hypertension Treatment]. Schweiz Med Wochenschr. 1996 Aug 17;126(33):1394-9. PubMed PMID: 8830397.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Rational hypertension treatment]. A1 - Canova,C R, PY - 1996/8/17/pubmed PY - 1996/8/17/medline PY - 1996/8/17/entrez SP - 1394 EP - 9 JF - Schweizerische medizinische Wochenschrift JO - Schweiz Med Wochenschr VL - 126 IS - 33 N2 - The primary objective of antihypertensive treatment is to prevent the involvement of target-organs, including hypertensive vascular disease of the kidney or left ventricular hypertrophy. Antihypertensive treatment should not worsen other cardiovascular risk factors (e.g. lipids) or impair quality of life. Contemporary efforts to optimize antihypertensive therapy are focused on single-drug therapy and on individualizing treatment according to patients age, sex, race and the presence of concomitant illnesses and therapies, in order to improve compliance and reduce overall cardiovascular morbidity and mortality. Several antihypertensive drugs such as ACE-inhibitors, beta-adrenergic-receptor antagonists, calcium channel blockers, diuretics, alpha-adrenergic-receptor antagonists, and newer substances such as imidazoline-receptor antagonists and angiotensin-II antagonists are discussed. SN - 0036-7672 UR - https://www.unboundmedicine.com/medline/citation/8830397/[Rational_hypertension_treatment]_ L2 - https://medlineplus.gov/highbloodpressure.html DB - PRIME DP - Unbound Medicine ER -